Medical Journals

Bovine Herpesvirus 1 Immediate-early Protein (Bicp0) Interacts with the Histone Acetyltransferase P300, Which Stimulates Productive Infection and Gc Promoter Activity.

Authors:
  • Zhang Yange
  • Jiang Yunquan
  • Geiser Vicki
  • Zhou Joe
  • Jones Clinton

From: Department of Veterinary and Biomedical Sciences, Nebraska Center for Virology, University of Nebraska, Lincoln, NE 68503, USA.

The Journal of general virology

  • Publish Date: Jul 2006
  • ISSN: 0022-1317
  • Volume: 87
  • Issue: Pt 7
  • Pages: 1843-51
  • Medium: Print
  • Language: English
  • Citation (JAMA): Zhang Yange, Jiang Yunquan, Geiser Vicki, et al. Bovine Herpesvirus 1 Immediate-early Protein (Bicp0) Interacts with the Histone Acetyltransferase P300, Which Stimulates Productive Infection and Gc Promoter Activity.. J. Gen. Virol. Jul 2006;87:1843-51

Abstract

The immediate-early protein, bICP0, of Bovine herpesvirus 1 (BHV-1) transactivates viral promoters and stimulates productive infection. bICP0 is expressed constitutively during productive infection, as its gene contains an immediate-early and an early promoter. Like other ICP0 homologues encoded by members of the subfamily Alphaherpesvirinae, bICP0 contains a zinc RING finger located near its N terminus. Mutations that disrupt the bICP0 zinc RING finger impair its ability to activate transcription, stimulate productive infection, inhibit interferon-dependent transcription in certain cell types and regulate subnuclear localization. bICP0 also interacts with a cellular chromatin-remodelling enzyme, histone deacetylase 1 (HDAC1), and can relieve HDAC1-mediated transcriptional repression, suggesting that bICP0 inhibits silencing of the viral genome. In this study, it was shown that bICP0 interacted with the histone acetyltransferase p300 during productive infection and in transiently transfected cells. In addition, p300 enhanced BHV-1 productive infection and transactivated a late viral promoter (gC). In contrast, a CH3-domain deletion mutant of p300, which is a dominant-negative mutant, did not activate the gC promoter. bICP0 and p300 cooperated to activate the gC promoter, suggesting that there is a synergistic effect on promoter activation. As p300 can activate certain antiviral signalling pathways (for example, interferon), it was hypothesized that interactions between p300 and bICP0 may dampen the antiviral response following infection.

Mesh Headings (Keywords): Amino Acid Sequence, Animals, Cattle, Cell Cycle Proteins, Cell Line, Cell Nucleus, Gene Expression Regulation, Viral, Genes, Viral, Herpesviridae Infections, Herpesvirus 1, Bovine, Histone Acetyltransferases, Humans, Molecular Sequence Data, Mutation, Promoter Regions (Genetics), Rabbits, Trans-Activators, Transcription Factors, Transfection, Ubiquitin-Protein Ligases, Viral Proteins, Zinc Fingers, p300-CBP Transcription Factors


Check for Full Text / PubMed Unique Identifier (PMID): 16760386


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.